LadRx Corporation (LADX)
OTCMKTS · Delayed Price · Currency is USD
1.050
+0.050 (5.00%)
Oct 1, 2025, 3:33 PM EDT
LadRx Market Cap
LadRx has a market cap or net worth of $495.09 thousand as of October 1, 2025. Its market cap has decreased by -23.08% in one year.
Market Cap
495.09K
Enterprise Value
288.14K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.05
Market Cap Chart
Since April 5, 1988, LadRx's market cap has decreased from 83.03M to 495.09K, a decrease of -99.40%. That is a compound annual growth rate of -12.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 30, 2025 | 495.09K | -40.48% |
| Dec 31, 2024 | 831.76K | 29.23% |
| Dec 29, 2023 | 643.62K | -87.57% |
| Dec 30, 2022 | 5.18M | -73.55% |
| Dec 31, 2021 | 19.58M | -69.32% |
| Dec 31, 2020 | 63.84M | 554.44% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.18M |
| Elite Pharmaceuticals | 726.52M |
| Tian'an Technology Group | 718.73M |
| Glass House Brands | 598.71M |
| Northwest Biotherapeutics | 382.67M |
| CytoDyn | 324.34M |
| Nika Pharmaceuticals | 301.74M |
| American Oncology Network | 273.17M |